ACAD
34.9
+0.65
+1.90%
AEMD
4.73
-0.03
-0.63%
APRI
0.423
0.00
0.00%
ARNA
1.63
+0.01
+0.62%
ATEC
0.195
-0.005
-2.6000%
CNAT
2.24
0.00
0.00%
CRXM
0.18
-0.001
-0.7735%
CYTX
2.93
-0.03
-1.01%
DXCM
64.97
+1.49
+2.35%
GNMK
6.87
+0.23
+3.46%
HALO
9.7
+0.38
+4.08%
ILMN
143.48
+3.65
+2.61%
INNV
0.26
+0.03
+14.58%
INO
11.13
+0.32
+2.96%
ISCO
2.3
+0.1
+4.55%
ISIS
57.56
0.00
0.00%
LGND
120.75
+1.45
+1.22%
LPTN
0.194
+0.017
+9.666%
MBVX
0.632
-0.009
-1.3281%
MEIP
1.39
+0.01
+0.72%
MNOV
6.71
+0.11
+1.67%
MRTX
17.48
+0.62
+3.68%
MSTX
0.306
-0.002
-0.6504%
NBIX
48.77
+0.7
+1.46%
NUVA
54.15
+0.93
+1.75%
ONCS
1.63
+0.02
+1.24%
ONVO
2.75
+0.16
+6.18%
OREX
0.426
+0.011
+2.750%
OTIC
13.68
+0.17
+1.26%
QDEL
16.39
+0.21
+1.30%
RCPT
231.96
0.00
0.00%
RGLS
5.85
+0.15
+2.63%
RMD
58.13
+0.71
+1.24%
SPHS
0.9
-0.02
-2.17%
SRNE
6.52
+0.09
+1.40%
TROV
5.29
+0.14
+2.72%
VICL
0.39
+0.00
+0.0256%
VOLC
18
0.00
0.00%
ZGNX
10.06
+0.5
+5.23%
ACAD
34.9
+0.65
+1.90%
AEMD
4.73
-0.03
-0.63%
APRI
0.423
0.00
0.00%
ARNA
1.63
+0.01
+0.62%
ATEC
0.195
-0.005
-2.6000%
CNAT
2.24
0.00
0.00%
CRXM
0.18
-0.001
-0.7735%
CYTX
2.93
-0.03
-1.01%
DXCM
64.97
+1.49
+2.35%
GNMK
6.87
+0.23
+3.46%
HALO
9.7
+0.38
+4.08%
ILMN
143.48
+3.65
+2.61%
INNV
0.26
+0.03
+14.58%
INO
11.13
+0.32
+2.96%
ISCO
2.3
+0.1
+4.55%
ISIS
57.56
0.00
0.00%
LGND
120.75
+1.45
+1.22%
LPTN
0.194
+0.017
+9.666%
MBVX
0.632
-0.009
-1.3281%
MEIP
1.39
+0.01
+0.72%
MNOV
6.71
+0.11
+1.67%
MRTX
17.48
+0.62
+3.68%
MSTX
0.306
-0.002
-0.6504%
NBIX
48.77
+0.7
+1.46%
NUVA
54.15
+0.93
+1.75%
ONCS
1.63
+0.02
+1.24%
ONVO
2.75
+0.16
+6.18%
OREX
0.426
+0.011
+2.750%
OTIC
13.68
+0.17
+1.26%
QDEL
16.39
+0.21
+1.30%
RCPT
231.96
0.00
0.00%
RGLS
5.85
+0.15
+2.63%
RMD
58.13
+0.71
+1.24%
SPHS
0.9
-0.02
-2.17%
SRNE
6.52
+0.09
+1.40%
TROV
5.29
+0.14
+2.72%
VICL
0.39
+0.00
+0.0256%
VOLC
18
0.00
0.00%
ZGNX
10.06
+0.5
+5.23%
Home » Archive by Category

Xconomy

Synthetic Biology Primer: In Conversation With Richard Kitney, Part 1

December 31, 2015 – 3:00 am

“Synthetic biology” has always been a puzzling term to me. Prosthetic limbs are synthetic. Knee replacements are synthetic. Splicing the gene from one organism into another, a practice…

[[Click headline to continue reading.]]

Synthetic Biology Primer: In Conversation With Richard Kitney, Part 1

December 31, 2015 – 3:00 am

“Synthetic biology” has always been a puzzling term to me. Prosthetic limbs are synthetic. Knee replacements are synthetic. Splicing the gene from one organism into another, a practice…

[[Click headline to continue reading.]]

Synthetic Biology Primer: In Conversation With Richard Kitney, Part 1

December 31, 2015 – 3:00 am

“Synthetic biology” has always been a puzzling term to me. Prosthetic limbs are synthetic. Knee replacements are synthetic. Splicing the gene from one organism into another, a practice…

[[Click headline to continue reading.]]

Thong Le: Biotech Thoughts On Pitches, Prices, Diversity, And Stress

December 30, 2015 – 4:00 am

Thong Le is the CEO of Accelerator, a Seattle biotech venture fund and incubator more than a decade old. Le took over in early 2014 and is overseeing a cross-country expansion. A second Accelerator…

[[Click headline to continue reading.]]

Thong Le: Biotech Thoughts On Pitches, Prices, Diversity, And Stress

December 30, 2015 – 4:00 am

Thong Le is the CEO of Accelerator, a Seattle biotech venture fund and incubator more than a decade old. Le took over in early 2014 and is overseeing a cross-country expansion. A second Accelerator…

[[Click headline to continue reading.]]

Innovation vs. Healthcare Spending: Biotech’s Biggest Looming Challenge

December 28, 2015 – 1:01 am

Let’s start with the good news. We are at the beginning of a transformation in human health, treating diseases in ways that we could only speculate about in the recent past. While biology isn’t quite…

[[Click headline to continue reading.]]

Innovation vs. Healthcare Spending: Biotech’s Biggest Looming Challenge

December 28, 2015 – 1:01 am

Let’s start with the good news. We are at the beginning of a transformation in human health, treating diseases in ways that we could only speculate about in the recent past. While biology isn’t quite…

[[Click headline to continue reading.]]

Innovation vs. Healthcare Spending: Biotech’s Biggest Looming Challenge

December 28, 2015 – 1:01 am

Let’s start with the good news. We are at the beginning of a transformation in human health, treating diseases in ways that we could only speculate about in the recent past. While biology isn’t quite…

[[Click headline to continue reading.]]

West Coast Bio Roundup: Shkreli, BlackThorn, Unhappy Holiday Layoffs

December 24, 2015 – 2:18 pm

As welcome rain falls on the West Coast, with snow farther east in our mountains, we wrap the year with—what else?—more Martin Shkreli-related drama at KaloBios Pharmaceuticals, which was…

[[Click headline to continue reading.]]

West Coast Bio Roundup: Shkreli, BlackThorn, Unhappy Holiday Layoffs

December 24, 2015 – 2:18 pm

As welcome rain falls on the West Coast, with snow farther east in our mountains, we wrap the year with—what else?—more Martin Shkreli-related drama at KaloBios Pharmaceuticals, which was…

[[Click headline to continue reading.]]